What are the leading causes of anticholinergic toxidrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Leading Causes of Anticholinergic Toxidrome

The leading causes of anticholinergic toxidrome are older antihistamines (diphenhydramine), muscle relaxants (cyclobenzaprine), overactive bladder agents (oxybutynin), tricyclic antidepressants, antipsychotics, sleep aids, cold preparations, atropine, and topical mydriatics 1, 2, 3.

Medication Classes Responsible for Anticholinergic Toxicity

The most common culprits fall into several distinct categories:

First-Generation Antihistamines

  • Diphenhydramine is the most frequently encountered agent 1, 2, 3
  • These older antihistamines have strong anticholinergic effects due to broad muscarinic receptor blockade 1
  • Commonly found in over-the-counter cold medicines and sleep aids 3, 4

Muscle Relaxants

  • Cyclobenzaprine is specifically highlighted as having strong anticholinergic properties 1
  • These are poorly tolerated, especially in elderly patients 1

Urological Agents

  • Oxybutynin and other overactive bladder medications 1
  • These agents directly target muscarinic receptors, making toxicity particularly pronounced

Psychiatric Medications

  • Tricyclic antidepressants are a major source 2, 3
  • Antipsychotics with anticholinergic properties 3

Other Common Sources

  • Atropine (including off-label sublingual use for sialorrhea) 2, 3, 5
  • Topical mydriatics used in ophthalmology 3
  • Antispasmodics 3
  • Over-the-counter cold preparations containing multiple anticholinergic agents 2, 3, 4

High-Risk Populations and Scenarios

Elderly Patients

The elderly are particularly vulnerable due to:

  • Declining acetylcholine physiology with aging 1
  • "Anticholinergic burden" from polypharmacy—taking multiple anticholinergic drugs simultaneously 1
  • Higher sensitivity to psychomotor impairment 6
  • Increased risk of falls, confusion, delirium, emergency department visits, and hospitalizations 1

Unintentional Exposures

  • Medication administration errors by caregivers, particularly those with visual impairment 5
  • Accidental pediatric ingestions of over-the-counter medications 7
  • Plant exposures: Jimson weed, deadly nightshade, and Hyoscyamus muticus (Egyptian henbane) 3, 8
  • Indirect exposure through food chain (rare but documented) 8

Intentional Exposures

  • Drug-facilitated scenarios involving scopolamine 9
  • Suicide attempts in younger patients 4
  • Recreational drug combinations with anticholinergics 4

Clinical Recognition: The Classic Toxidrome

The anticholinergic syndrome is classically described as: "Red as a beet, dry as a bone, hot as a hare, blind as a bat, mad as a hatter, full as a flask" 2.

Key clinical features 2:

  • Mental status: Agitated delirium, hallucinations, confusion
  • Vital signs: Mild fever (<38.8°C), tachycardia, mild hypertension
  • Pupils: Mydriasis (dilated pupils)
  • Skin: Hot, dry, erythematous
  • Mucous membranes: Dry
  • Gastrointestinal: Hypoactive or absent bowel sounds, urinary retention
  • Neuromuscular: Normal muscle tone (distinguishes from serotonin syndrome and NMS)
  • Onset: Minutes to hours (usual: 0.5-24 hours) 2

Critical Pitfalls to Avoid

Over-the-Counter Medication Underestimation

Many clinicians fail to recognize that readily available cold medicines and sleep aids can produce severe toxicity, even in younger patients with normal renal function 4. Always obtain detailed medication reconciliation including all OTC products 5.

Synergistic Toxicity

OTC formulations often contain multiple anticholinergic agents (e.g., chlorpheniramine + scopolamine), leading to additive or synergistic effects 7. Consider cumulative anticholinergic burden rather than individual drug effects.

Diagnostic Limitations

Standard urine immunoassay screening is frequently negative for anticholinergic agents 7, 9. The diagnosis is clinical, based on toxidrome recognition. Advanced testing (liquid chromatography-mass spectrometry or gas chromatography-mass spectrometry) may be needed for confirmation but should not delay treatment 7, 9.

Caregiver-Related Factors

When prescribing medications requiring precise dosing (like sublingual atropine), assess both patient and caregiver ability to administer safely 5. Visual impairment, cognitive decline, or language barriers can lead to inadvertent overdose.

Management Approach

Immediate actions 2:

  1. Discontinue the precipitant drug
  2. Supportive care: IV fluids, cooling measures for hyperthermia
  3. Benzodiazepines for agitation and seizures
  4. Sodium bicarbonate for prolonged QRS or dysrhythmias (particularly with tricyclic antidepressants)
  5. Physostigmine for severe cases with life-threatening features 2

Physostigmine considerations: Reserved for severe toxicity with altered mental status, seizures, or hemodynamic instability. Contraindicated in patients with cardiac conduction abnormalities or asthma 2.

The evidence consistently demonstrates that over 600 compounds possess anticholinergic properties 3, making this toxidrome one of the most commonly encountered in emergency medicine. Recognition requires high clinical suspicion, particularly when standard toxicology screening is negative.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.